Litigation Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Docket		Date Filed	2018-02-22
Court	District Court, D. Delaware	Date Terminated	2020-10-07
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To	Christopher J. Burke
Parties	COLLEGIUM PHARMACEUTICAL, INC.
Patents	10,004,729; 7,399,488; 7,771,707; 8,449,909; 8,557,291; 8,758,813; 8,840,928; 9,044,398; 9,248,195; 9,592,200; 9,682,075; 9,737,530; 9,763,883; 9,968,598
Attorneys	Karen Elizabeth Keller
Firms	Shaw Keller LLP, I.M. Pei Building
Link to Docket	External link to docket

Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-02-21	1		before the expiration of, Collegium’s U.S. Patents Nos. 7,399,488; 7,771,707; 8,449,909; 8,557,291; 8,758,813…is an action for relief from patent infringement, arising under the patent laws of Title 35, United States…Notice of Patent Certification asserting it intends to launch its copy before Collegium’s patents to its…of infringement of the Asserted Patents under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A). …of infringement of the Asserted Patents under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A).	External link to document
2019-09-11	107	Report and Recommendations	x27;"883 patent"), 9,968,598 (the '"598 patent") and 10,004,729 (the '"…infringement of 13 patents: United States Patent Nos. 7,771,707 (the "'707 patent"), 8,449,…"729 patent" and collectively with the other patents, "the asserted patents"). Presently…8,449,909 (the "'909 patent"), 8,557,291 (the "'291 patent"), 8,758,813 (the … "'813 patent"), 8,840,928 (the '"928 patent"), 9,044,398 (the '"	External link to document